Leukemia is a deadly cancer disease, and according to World Health Organization (WHO)
data, there were 437,033 cases across the world in 2018. Early detection of this cancer is …

Leukemia is a cancer of blood cells and bone marrow, leading to death in many patients
mainly in children. Over the last several years, aptamers generated by SELEX (Systematic …

Cancer is a real menace to all societies globally since it is the leading cause of premature
mortality in men and women. The incidence of malignancies is enhancing as a result of …

Aptamers are specific oligonucleotides selected invitro which bind to target molecules with
high affinity and specificity like antibody-antigen interactions. For that reason, these synthetic …

Early diagnostics of leukemia is crucial for successful therapy of this disease. Therefore,
development of rapid, sensitive, and easy-to-use methods for detection of this disease is of …

The early diagnosis of diseases is of great importance for the effective treatment of patients.
Biomarkers are one of the most promising medical approaches in the diagnosis of diseases …

Cancer is the second most extended disease during the world with an improved death rate
over the past several time. Due to the restrictions of cancer analysis methods, the patient's …

Nanobiosensors based on aptamer are extensively being studied as potent analytical tools
in clinical analysis. These biosensors provide high sensitivity, fast response, specificity and …

A simple and rapid electrochemical aptamer cytosensor has been developed for direct
detection of chronic myelogenous leukemia (CML) K562 cells based on a specific aptamer …

Aptamers are short length, single‐stranded DNA or RNA affinity molecules which interact
with any desired targets such as biomarkers, cells, biological molecules, drugs or chemicals …